🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

UHNM has become the first NHS Trust in England to partner with Blood Cancer UK to trial a new referral tool aimed at improving access to a range of emotional and practical support. Find out more ➡️ uhnm.nhs.uk/latest-uhnm-ne…

Absolutely great shout out for our clinical trials admin team.

Thanks to our research midwife, Louise, and to all midwives who do an amazing job 😊

New IMS high risk definition for multiple myeloma presented by Prof Corre COMy . Fantastic effort by co-operative groups to redefine risk. Clearly an evolving area.

A year ago Department of Health and Social Care published the O’Shaughnessy report - the result of a detailed review of commercial clinical trials in the UK by James O'Shaughnessy. Our Chair Nick McNally interviewed James to discuss his reflections on progress made over the last 12 months ukrdleaders.org/2024/05/23/jam…

Is high levels of soluble BCMA the Achilles heel for BCMA bispecific antibodies? Another amazing talk from nizar jacques bahlis COMy

Great news that we now have Teclistamab, another BCMA bispecific antibody available as well as Elranatamab for myeloma patients. But still more work to do to widen access to Pomalidomide exposed patients.

We’re about to start our World Cafe session - enabling all our delegates here today to discuss key issues they’d like to see addressed by the UKRD Inclusion Working Group. Coproduction of our priorities in action!

Treatment of newly diagnosed myeloma in one slide. Based on 4 recent phase IIIs practice has changed and has become easier. #MyelomaVR

Sad that European Hematology Association #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!

Looking forward to an exciting academic meeting as well as seeing friends and colleagues at the 11th UK Amyloidosis Workshop on Wednesday at Royal Free London with star guest speakers Sharmila Dorbala Cappelli Francesco and Prof arnaud Jaccard

Starting Monday!! #CeNREE will be exhibiting posters from the UHNM Showcase Event 'Exceptional Care, Exceptional People' (research stream). Join us in the main atrium at Royal Stoke to celebrate and view staffs great work 👏 drop-in and say hello to the team 😀

British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

Far too often myeloma is mistaken for signs of ageing and is left to progress untreated. Thank you to Simon for sharing his story this #BloodCancerAwarenessMonth mirror.co.uk/news/uk-news/i…

Three UHNM consultants have been awarded research professorships in recognition of their career achievements. 🎓👏✨ Dr Pensee Wu, Dr Mark Lambie, and Dr Timothy Scott have carried out research projects at UHNM as well as national and internationally ➡️ uhnm.nhs.uk/latest-uhnm-ne…

Are you a patient that has had chemotherapy. We have a survey to better understand skin changes. Please retweet and share widely. 🙏 qualtrics.ucl.ac.uk/jfe/form/SV_b3… Richard Simcock Dr Liz O'Riordan Breast Cancer Now Ovacome - the ovarian cancer support charity

Post-CCT HPB Fellowship at UHNM NHS Trust 🏥 advert now out. Fantastic opportunity for Senior Resident HPB Surgeons. High volume pancreaticobiliary surgery, complex elective and emergency biliary pathology. Laparoscopic and robotic surgery, 60-70 resections per year, over 450 emergency

Need help setting up a bispecific antibody service for myeloma? We’re sharing protocols to all to help widen access for patients See our website UCL 👇#mmsm

Please complete this survey..

We are looking for 🇬🇧 healthcare professionals for an NIHR-funded study on #preeclampsia. Please contact me for more details, thank you! ☺️